股票 › TSHA
泰莎基因治疗 TSHA
美股市值排名 #2991
$4.33 +$0.24 (+5.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.33 0.00%
开盘$4.16
昨收$4.09
当日区间$4.14 – $4.45
成交量3.18M
市值$1.41B
市盈率（TTM）–
股息率–
TSHA 相关新闻
匹配 Taysha Gene Therapies 或代码 TSHA 的头条新闻，按最新排序。
- Wolfe Research Initiates Taysha Gene Therapies(TSHA.US) With Buy Rating
- BofA Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating
- CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $17
- Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12
- Cantor Fitzgerald Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $19
- Piper Sandler Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12
- Goldman Sachs Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $13
- Goldman Sachs Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $13 正面
- BMO Capital Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $14
- A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $12 to $15
- Piper Sandler Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $12 正面
- Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)
- Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $15 正面
- BMO Capital Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $14 正面
- BofA Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $10 正面
暂无评论——快来第一个聊聊 TSHA。
登录后参与讨论。